Statement Of Cash Flows [Abstract]
| Concept |
2021-01-01 to 2021-12-31 |
2020-01-01 to 2020-12-31 |
|---|---|---|
| Statement of cash flows [abstract] | ||
| Cash flows from (used in) operating activities [abstract] | ||
| Adjustments for decrease (increase) in trade and other receivables |
493,831,000
DKK
|
48,252,000
DKK
|
| Adjustments for depreciation and amortisation expense and impairment loss (reversal of impairment loss) recognised in profit or loss |
530,434,000
DKK
|
446,501,000
DKK
|
| Adjustments for gains (losses) on change in fair value less costs to sell, biological assets |
434,868,000
DKK
|
118,003,000
DKK
|
| Adjustments for undistributed profits of investments accounted for using equity method |
30,112,000
DKK
|
5,546,000
DKK
|
| Cash flows from (used in) financing activities [abstract] | ||
| Cash flows from (used in) increase (decrease) in current borrowings |
404,600,000
DKK
|
107,451,000
DKK
|